The impact of heart failure on the classification of COPD severity

Journal of Cardiac Failure

Volumn 18, Issue 8, 2012, Pages 637-644

  Güder, Gülmisal ^a,b   Rutten, Frans H ^b   Brenner, Susanne ^a   Angermann, Christiane E ^a   Berliner, Dominik ^a,c   Ertl, Georg ^a   Jany, Berthold ^d   Lammers, Jan Willem J ^b   Hoes, Arno W ^b   Störk, Stefan ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Missionsarztliche Klinik   (Germany)

Author keywords

COPD; Heart failure; severity classification

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOBAL INITIATIVE OF CHRONIC OBSTRUCTIVE LUNG DISEASE CLASSIFICATION; HEART FAILURE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAGING; TOTAL LUNG CAPACITY;

AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84864446613     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.05.008     Document Type: Article

References (32)

1. R.A. Pauwels, A.S. Buist, P. Ma, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary Respir Care 46 2001 798 825
2. M.P. Swanney, G. Ruppel, P.L. Enright, O.F. Pedersen, R.O. Crapo, and M.R. Miller Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction Thorax 63 2008 1046 1051
3. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
4. R.W. Light, and R.B. George Serial pulmonary function in patients with acute heart failure Arch Intern Med 143 1983 429 433
5. P. Faggiano Abnormalities of pulmonary function in congestive heart failure Int J Cardiol 44 1994 1 8
6. I. Dimopoulou, M. Daganou, O.K. Tsintzas, and G.E. Tzelepis Effects of severity of long-standing congestive heart failure on pulmonary function Respir Med 92 1998 1321 1325
7. N.M. Hawkins, M.C. Petrie, P.S. Jhund, G.W. Chalmers, F.G. Dunn, and J.J. McMurray Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail 11 2009 130 139
8. F.H. Rutten, M.J. Cramer, J.W. Lammers, D.E. Grobbee, and A.W. Hoes Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 8 2006 706 711
9. K.K. Iversen, J. Kjaergaard, D. Akkan, L. Kober, C. Torp-Pedersen, and C. Hassager Chronic obstructive pulmonary disease in patients admitted with heart failure J Intern Med 264 2008 361 369
10. F.H. Rutten, M.J. Cramer, D.E. Grobbee, A.P. Sachs, J.H. Kirkels, and J.W. Lammers Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 26 2005 1887 1894
11. R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, and R. Casaburi Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
12. J. Mascarenhas, P. Lourenco, R. Lopes, A. Azevedo, and P. Bettencourt Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications Am Heart J 155 2008 521 525
13. Z.S. Gardner, D.A. Kaminsky, and G.L. Ruppel Grading the severity of obstruction in mixed obstructive-restrictive lung disease [abstract] Am J Respir Crit Care Med 181 2010 A2107
14. D.H. Au, E.M. Udris, V.S. Fan, J.R. Curtis, M.B. McDonell, and S.D. Fihn Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction Chest 123 2003 1964 1969
15. O. Hirono, I. Kubota, O. Minamihaba, K. Fatema, S. Kato, and H. Nakamura Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists Am Heart J 142 2001 E11
16. S.R. Salpeter Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review Drugs Aging 21 2004 405 414
17. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 1439 1450
18. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
19. L.C. Boudestein, F.H. Rutten, M.J. Cramer, J.W. Lammers, and A.W. Hoes The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease Eur J Heart Fail 11 2009 1182 1188
20. C.E. Angermann, S. Stork, G. Gelbrich, H. Faller, R. Jahns, and S. Frantz Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) Study Circ Heart Fail 5 2011 25 35
21. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
22. E.D. Folland, A.F. Parisi, P.F. Moynihan, D.R. Jones, C.L. Feldman, and D.E. Tow Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques Circulation 60 1979 760 766
23. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur Respir J Suppl 16 1993 5 40
24. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society Am Rev Respir Dis 144 1991 1202 1218
25. S. Greenland, and W.D. Finkle A critical look at methods for handling missing covariates in epidemiologic regression analyses Am J Epidemiol 142 1995 1255 1264
26. A.H. Bowker A test for symmetry in contingency tables J Am Stat Assoc 43 1948 572 574
27. W.B. Kannel, J.M. Seidman, W. Fercho, and W.P. Castelli Vital capacity and congestive heart failure. The Framingham study Circulation 49 1974 1160 1166
28. K. Kee, and M.T. Naughton Heart failure and the lung Circ J 74 2010 2507 2516
29. H.A. Kerstjens The GOLD classification has not advanced understanding of COPD Am J Respir Crit Care Med 170 2004 212 214
30. C. Esteban, J.M. Quintana, M. Egurrola, J. Moraza, M. Aburto, and J. Perez-Izquierdo Classifying the severity of COPD: are the new severity scales better than the old? Int J Tuberc Lung Dis 13 2009 783 790
31. A.H.K.R. Morris, and R.O. Crapo Clinical pulmonary function testing: a manual of uniform laboratory procedures 1984 Intermountain Thoracic Society Salt Lake City, [UT]
32. S. Schembri, W. Anderson, S. Morant, J. Winter, P. Thompson, and D. Pettitt A predictive model of hospitalisation and death from chronic obstructive pulmonary disease Respir Med 103 2009 1461 1467